Perjeta 420 mg
Perjeta 420 mg is a medicine authorised by Swissmedic under authorisation number 62510. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 13 August 2012 and the authorisation is valid without a time limit. ATC code L01FD02 places the medicine in the group Antineoplastic agents.
| Authorisation number | 62510 |
|---|---|
| Name | Perjeta 420 mg |
| Full name | Perjeta 420 mg, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Roche Pharma (Schweiz) AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FD02 |
| First authorisation | 13 August 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Perjeta 420 mg, Konzentrat zur Herstellung einer Infusionslösung | A | 13 August 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FD02 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Perjeta 420 mg authorised in Switzerland?
Yes. Perjeta 420 mg is authorised by Swissmedic under authorisation number 62510, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Perjeta 420 mg have?
Perjeta 420 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Perjeta 420 mg?
The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.